Estimating Long-Term Survivorship Rates Among Patients With Resected Stage III/IV Melanoma: Analyses From CheckMate 238 and European Organization for Research and Treatment of Cancer 18071 Trials.
Saved in:
| Title: | Estimating Long-Term Survivorship Rates Among Patients With Resected Stage III/IV Melanoma: Analyses From CheckMate 238 and European Organization for Research and Treatment of Cancer 18071 Trials. |
|---|---|
| Authors: | Weber JS; New York University Perlmutter Cancer Center, New York, NY.; Deceased., Middleton MR; University of Oxford, Oxford, United Kingdom., Yates G; Parexel International, London, United Kingdom., Sharpe DJ; Parexel International, London, United Kingdom., Kurt M; Bristol Myers Squibb, Princeton, NJ., Lobo M; Bristol Myers Squibb, Princeton, NJ., Moshyk A; Bristol Myers Squibb, Princeton, NJ., Vanderpuye-Orgle J; Parexel International, Los Angeles, CA., Mohr P; Elbe Kliniken Buxtehude, Buxtehude, Germany. |
| Source: | Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2025 Mar 10; Vol. 43 (8), pp. 929-937. Date of Electronic Publication: 2024 Oct 08. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
